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a  b  s  t  r  a  c  t
This  study  evaluated  the  effects  of  antiandrogen  exposure  during  the  prepubertal  period  on  reproductive
development  and  reproductive  competence  in  adults.  Male  rats  were  divided  into  two  groups:  ﬂutamide,
receiving  25  mg/kg/day  of  ﬂutamide  by oral  gavage  and  control,  receiving  vehicle  daily.  Dosing  continued
from  PND  21 to 44,  and  animals  were  killed  on  PND  50 or  PND  75–80.  The  epididymis,  prostate,  vas  defer-
ens  and  seminal  vesicle  weights  were  lower  in  Flutamide  group  on  PND  50,  while  on  PND  80 only  seminal
vesicle  weight  was  reduced.  Fertility  assessed  by  IUI revealed  a  decrease  in  the  fertility  potential  in  the
ﬂutamide-treated  adults.  Flutamide  accelerated  sperm  transit  time  through  the  epididymis,  impairing
sperm  motility  and  storage.  A  quantitative  analysis  of  the  cauda  sperm  membrane  proteome  revealed  a
few signiﬁcant  changes  in  protein  expression.  Thus,  exposure  to  ﬂutamide  during  the prepubertal  period
compromises  the  function  of  the  epididymis  along  with  epididymal  sperm  quality  at  adulthood.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
The epididymis, a highly convoluted duct that connects the
efferent ducts to the vas deferens, plays a crucial role in the
acquisition of progressive sperm motility and ultimate fertilizing
ability [1,2]. A signiﬁcant facet of this maturation process involves
reorganization of the molecular architecture of the sperm plasma
membrane. Membrane proteins are shed, acquired, and modiﬁed as
lipid composition changes [3].  Some of these changes are directly
pivotal to maturation of the sperm, but others are protective in
nature [4].  The mature sperm remain protected during storage in
the most distal regions of the epididymis until they are ejaculated
or voided in the urine.
Abbreviations: PND, postnatal day; IUI, in utero insemination; GD, gestational
day.
∗ Corresponding author at: Departamento de Morfologia, Instituto de Biociências,
UNESP, Caixa Postal 510, 18618-970 Botucatu, SP, Brazil.
Tel.: +55 14 3811 6264x104; fax: +55 14 3811 6264x102.
E-mail address: jperobelli@gmail.com (J.E. Perobelli).
Speciﬁc functions occur within different regions of the epi-
didymis with specialized microenvironments created along the
interior of the epididymal duct [5].  These regional differences are
established during the period of postnatal development of the epi-
didymis, from PND 15 to 44 [6].  During this period the epididymis
undergoes the requisite morphological and functional changes that
resulting this regional differentiation of the duct; distinct gene and
protein expression proﬁles can be found [7].  This differentiation of
the epididymis is driven largely by the increase in circulating andro-
gen that occurs around the time of puberty [8].  Studies are needed
to elucidate damage to sperm maturation arising from disruption
of the differentiation process during development.
The present study was undertaken to interfere with the prepu-
bertal period of differentiation in order to understand the possible
adverse effects on sperm quantity and quality at adulthood. We
elected to attempt to alter the differentiation of the epididymis with
ﬂutamide, a potent non-steroidal antiandrogen [9] that competes
for the androgen receptor and is capable of reducing the physio-
logical action of testosterone on target tissues when endogenous
tissue levels of androgen are submaximal [10,11]. Between PND 21
and 44 androgen levels in the epididymis are on the rise, but far
0890-6238/$ – see front matter ©  2011 Elsevier Inc. All rights reserved.
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less than adult levels [8].  The choice of an anti-androgen agent was
due to extensive environmental exposure of the general population
to this group of endocrine disruptors, which include agricultural
pesticides, industrial chemicals, pharmaceuticals, and others, many
times occurring as complex mixtures of anti-androgens that need
not have a common active metabolite to produce cumulative
adverse effects [12–15].  Based on the notion that developmental
exposure to endocrine disruptive chemicals may  have adverse con-
sequences on reproductive competence in men, we  believe that this
experimental model is currently relevant to toxicology as well as
reproductive biology.
2. Material and methods
2.1. Animals
Immature Wistar male rats (21 days old) and Wistar female rats (45 days old)
were supplied by the Central Biotherium of UNESP – Univ Estadual Paulista. During
the  experiment, animals were allocated individually in polypropylene cages, with
laboratory grade pine shavings as bedding. Rats were maintained under controlled
temperature (±23 ◦C) and lighting conditions (12 L/12 D photoperiod). Rat chow
(Purina Labina, Agribrands do Brasil Ltda, Paulínia/SP) and ﬁltered tap water were
provided ad libitum. Experimental procedures were in accordance with the Ethical
Principles in Animal Research adopted by the Brazilian College of Animal Experimen-
tation and were approved by the Biosciences Institute/UNESP Ethics Committee for
Animal Research (protocol number 21/08).
2.2. Experimental design
Male rats were randomly divided into two  experimental groups: control group
(C,  n = 30) and ﬂutamide group (F, n = 30). The F group rats received daily oral gavage
doses of ﬂutamide (Sigma Aldrich–25 mg/kg, at a volume of 3 ml/kg) diluted in corn
oil,  while C group received only the vehicle (corn oil), at the same volume. Animals
were treated from PND 21 to PND 44 corresponding to the prepubertal development
of  the epididymis. Rats were weighed daily during treatment and on alternate days
after treatment. The dose of ﬂutamide chosen in this study is effectively antiandro-
genic, as described previously [16]. No clinical signs of toxicity were observed in
any  of the experiments herein described. The study was conducted in two  steps;
Experiment 1 and Experiment 2, and described as follows.
2.3. Experiment 1
In this experiment, male (n = 40) and female (n = 30) Wistar rats were used. The
age  at acquisition of preputial separation was evaluated starting on PND 30 as an
indicator of the onset of puberty. The observation criterion adopted was the age
when the prepuce ﬁrst separates from the glans penis, not considering the complete
retraction of the prepuce [17]. On PND 50, 20 male rats (n = 10/group) were killed
for  an evaluation of reproductive organ weights and serum hormone levels. The
other 20 male rats (n = 10/group) were evaluated at 70 days of age for sexual behav-
ior and reproductive competence following natural mating with naïve females. A
10-day post-mating interval was allowed to permit recovery of sperm reserves;
subsequently, at the age of 80 days these male were killed for evaluation of repro-
ductive organ weights, sexual hormone levels, sperm motility and morphology, and
the sperm membrane proteome.
2.3.1. Evaluation of sexual behavior and natural mating
At 70 days of age, male rats from each experimental group (n = 10/group)
were placed individually in polycarbonate crystal boxes, measuring
44  cm × 31 cm × 16 cm,  5 min  before introduction of one sexually receptive, adult
female rat (70 days old). Sexual receptivity was determined by vaginal smear and by
lordosis exhibition in the presence of a sexually experienced, vasectomized male of
proven sterility. These females were synchronized to achieve estrous with a single
subcutaneous injection of 80 g of luteinizing releasing hormone (LHRH) agonist
(Sigma Chemical Co., St Louis, MO)  approximately 115 h prior to the sexual behavior
evaluation.
Paired animals were observed in the dark period of the cycle in a separate
room under dim red light and all sexual behavior tests were performed 2–4 h
after  the beginning of the dark period. The following parameters were observed
for 40 min: latency to the ﬁrst mount, intromission, and ejaculation; number
of  intromissions until the ﬁrst ejaculation; latency of the ﬁrst post-ejaculatory
intromission; number of post-ejaculatory intromissions; and total number of
ejaculations [18–22].  Males that did not mount in the initial 10 min  were consid-
ered sexually inactive. After the sexual behavior evaluation was complete, paired
animals were kept together for an additional 4 h. After this period, males and
females were separated and vaginal smears were collected to conﬁrm that mating
occurred.
2.3.2. Fertility evaluation
Twenty days later (GD20), naturally inseminated females were killed by decap-
itation. After collection of the uterus and ovaries the numbers of corpora lutea,
implants, reabsorptions, live and dead fetuses were determined. From these
results the following parameters were calculated: fertility potential (efﬁciency
of  implantation): implantation sites/corpora lutea × 100; rate of preimplantation
loss: [number of corpora lutea −number of implantations/number of corpora
lutea] ×100; and rate of postimplantation loss: [number of implantations − number
of  live fetuses]/number of implantations ×100.
2.3.3. Euthanasia, body weight and reproductive organ weights of male rats
At  50 or 80 days of age 10 male rats per experimental group were killed by
decapitation. The right testis, epididymis and vas deferens, ventral prostate and
seminal vesicle (without the coagulating gland) were removed and their wet weights
(absolute and relative to body weight) were recorded.
2.3.4. Serum testosterone, FSH and LH levels
After decapitation, blood was collected (between 9:00 and 11:30 AM)  and serum
was  obtained by centrifugation (1236 × g, for 20 min at 4 ◦C). The concentrations of
testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were
determined by the technique of double antibody radioimmunoassay. Testosterone
assay was performed using a TESTOSTERONE MAIA® kit (Biochem Immuno Sys-
tem). The LH and FSH assays were done using speciﬁc kits supplied by the National
Institute of Arthritis, Diabetes and Kidney Diseases (NIADDK, USA). All samples
were assayed in duplicate and in the same assay to avoid inter-assay errors. The
intra-assay error was 3.4% for LH, 2.8% for FSH and 4% for testosterone.
2.3.5. Sperm motility and morphology
Immediately after euthanasia of 80-day-old animals, sperm were obtained from
the left vas deferens duct and diluted in 2 ml  of modiﬁed HTF medium (Human
Tubular Fluid, IrvineScientiﬁc®), pre-warmed at 34 ◦C. A 10 l aliquot was placed in
a  Makler chamber (Irvine, Israel) and analyzed under a phase-contrast microscope
(Leica DMLS) at 200× magniﬁcation. One hundred sperm were evaluated per animal
and classiﬁed for motility into: type A: mobile, with progressive trajectory; type B:
mobile, with non-progressive trajectory; type C: immotile [23].
With the aid of a syringe and needle, sperm were recovered from the right vas
deferens by ﬂushing with 1.0 ml of saline formol. To analyze the sperm morphologi-
cally, smears were prepared on histological slides that were left to dry for 90 min  and
200 spermatozoa per animal were analyzed in a phase-contrast microscope (400×
magniﬁcation) [24]. Morphological abnormalities were classiﬁed into two  general
categories: head morphology (without curvature, without characteristic curvature,
pin head or isolated form, i.e., no tail attached) and tail morphology (broken or rolled
into a spiral) [25]. Sperm were also classiﬁed as to the presence or absence of the
cytoplasmic droplet.
2.3.6. Quantitative evaluation of the sperm membrane proteome
Sperm were obtained from the proximal cauda epididymis [26] by nicking the
duct with a number 11 scalpel and allowing sperm to disperse into 2 ml  of Sperm
Isolation Buffer (95 ml/l 10× HBSS, 0.35 g/l NaHCO3, 4.2 g/l HEPES, 0.9 g/l glucose,
10  ml/l Na pyruvate, 25 mg/l STI, pH 7.4). One ml  was transferred to a microcen-
trifuge tube and washed twice by centrifugation (2000 rpm, 5 min, 4 ◦C) in the same
buffer, with freshly-added 0.2 mM phenylmethylsulphonyl ﬂuoride (PMSF, Sigma,
St.  Louis, MO). After the ﬁnal wash, sperm were extracted for 1 h at room tempera-
ture with 1 ml  of 80 mM n-octyl-B-glucopyranoside in 10 mM Tris, pH 7.2 containing
freshly added PMSF. Following a ﬁnal centrifugation (2000 rpm, 5 min, 4 ◦C), the
supernatant was  removed and frozen (−70 ◦C).
Prior to 2-D gel electrophoresis, samples were thawed, and each extract was con-
centrated with 1 mM Tris buffer, pH 7.2, by three centrifugations (3,000 rpm, 30 min,
4 ◦C) in Ultrafree-4 centrifugation ﬁlter units (Millipore, Bedford, MA). Protein con-
centration was determined by the Bradford method, using Bradford Reagent (Sigma
Aldrich®). The absorbance was read by spectrophotometry (SPECTRO 22RS, Digital
Spectrophotometer – Quimis) and protein concentrations determined by interpo-
lation from standard curve using seven different albumin concentrations (g/ml):
0, 60, 80, 100, 200, 400 and 600 (R2 = 0.99). Sample volumes containing 30 g of
protein were lyophilized, and protein was solubilized for 30 min  at room tempera-
ture in 45 l of sample buffer consisting of 5.7 g of urea, 4 ml of 10% NP-40, 0.5 ml
of  ampholytes (3–10 only; Serva, Heidelberg), and 0.1 g of dithiothreitol per 10 ml.
Isoelectric focusing (750 V, 3.5 h) was carried out in capillary tube gels consisting of
6.24 g of urea, 1.5 ml of acrylamide solution (30% acrylamide, 1.2% bisacrylamide),
2.25  ml  of 10% NP-40, and 0.65 ml  of ampholytes (3–10 only) per 10 ml.  Molecular
weight separation was carried out in mini 14% acrylamide gels (200 V, 1 h). Gels were
ﬁxed in 40% ethanol (v/v) and 10% acetic acid (v/v) in ultrapure water, ﬂuorescence
stained using Krypton Protein Stain (Pierce Biotechnology) and, ﬁnally, immersed
in  destaining solution (5% acetic acid in ultrapure water) for 5 min.
A  Fluoro Image Analyser (FLA-5100; Fujiﬁlm) was used to scan gels and cap-
ture high resolution images with a 532 nm laser light source. Progenesis Same
Spots Software (2.0) was  used for background correction, spot matching, and spot
area  quantiﬁcation. Spots corresponding to proteins whose expression was  signiﬁ-
cantly altered (upregulated or downregulated) were punched from 2D gels using an
automated Ettan spot picker. Gel punches were destained twice in an ammonium
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Table 1
Age of preputial separation and sexual behavior parameters of male rats at 70 days old.
Experimental groups
Control (n = 10) Flutamide (n = 10)
aPreputial separation (days) 32.55 ± 0.34 33.70 ± 0.38*
bLatency to the ﬁrst intromission (s) 118.20 ± 24.66 (10) 205.27 ± 46.35 (10)
bNumber of intromissions until the ﬁrst ejaculation 18.30 ± 2.40 (10) 15.36 ± 1.59 (10)
bLatency to the ﬁrst ejaculation (s) 794.67 ± 58.92 (9) 790.82 ± 94.52 (10)
bFirst post-ejaculatory intromission (s) 1108.1 ± 66.32 (9) 1110.3 ± 102.41 (10)
bLatency to the ﬁrst post-ejaculatory intromission (s) 313.44 ± 11.90 (9) 319.45 ± 14.32 (10)
bNumber of post-ejaculatory intromissions 20.22 ± 3.74 (9) 18.91 ± 1.94 (10)
bNumber of ejaculations 2.33 ± 0.16 (9) 2.45 ± 0.21 (10)
a Values expressed as mean ± SEM. Student’s t test.
b Values expressed as mean ± SEM. Mann–Whitney test. Times are expressed in s. The number of animals that presented the behavior is indicated in parentheses.
* p < 0.05.
bicarbonate solution, dehydrated by acetonitrile and dried in a SpeedVac. An small
volume of trypsin solution was added, the tubes placed in a Thermomixer (300 rpm,
37 ◦C). Additional 20–30 l of a digestion solution was added and the incubation
continued overnight; digestion was terminated with TFA. Peptides extracted directly
from the solution using C18 ZipTips, were desalted and eluted onto a MALDI plate in a
minimal volume of MALDI matrix solution in 80% acetonitrile–20% water. The MSMS
data was  processed using Protein Pilot 3.0 software (ABI, Inc.). Chemical background-
subtracted MALDI-MS data were processed on-line using the Aldente software. A
targeted MALDI-MSMS analysis was  done using an additional spot plated for each
sample using a second-round of gel plug peptide extraction.
2.4. Experiment 2
2.4.1. In utero insemination (IUI)
Because rats produce and ejaculate an excess of qualitatively normal sperm, the
insemination in utero of a ﬁxed, critical number of sperm has been proven to increase
the sensitivity for detecting a decrease in sperm quality in the rat [27]; alterations
in  sexual behavior and/or sperm production and availability are not issues.
A  group of adult females (n = 30) were synchronized to be in estrous on the
day  of insemination as described previously. Shortly after room lights were turned
off  on the day of proestrus, the synchronized females were paired with the sexu-
ally  experienced, vasectomized males of proven sterility for 1 h. Receptive females
(i.e. those that exhibited lordosis) were selected for insemination. Proximal cauda
sperm were isolated and prepared for insemination as previously described [28,29],
with the following adaptations. Brieﬂy, the sperm were released from the proximal
cauda of adult animals (75 days old) by nicking the duct with a number 11 scalpel
and allowed to disperse into 2 ml  of modiﬁed HTF media (Human Tubular Fluid,
IrvineScientiﬁc®). After allowing 5 min  for dispersion, a sperm aliquot was diluted
1:10  with ﬁxative (10% formalin in PBS) and counted using a Neubauer chamber.
Within 15 min, each uterine horn was injected with a volume containing 5 × 106
sperm [24]. One female was  inseminated per male. All inseminations were per-
formed while the recipient female was in a surgical plane using a mix  of ketamine
and  xylazine for the anesthesia. The bifurcation of the uterine horns was exposed
through a low midventral incision and each horn was  inseminated using a nee-
dle (13 × 0.45 mm)  attached to a 1.0-ml syringe. Each injection site was cauterized
immediately upon withdrawal of the needle. When insemination was completed,
the abdominal musculature was sutured. Twenty days later (GD20), the artiﬁcially
inseminated females were euthanized by decapitation to enable evaluation and cal-
culation of the fertility and reproductive performance parameters, as previously
described in Section 2.3.3.
2.4.2. Daily sperm production per testis, sperm number and transit time in the
epididymis
The right testis and epididymis of 75-day-old animals were used for sperm
counts. Homogenization-resistant testicular spermatids (stage 19 of spermiogene-
sis)  in the testis were counted as described previously [30], with adaptations adopted
by  Fernandes et al. [31]. Brieﬂy, the testis, decapsulated and weighed soon after
collection, was  homogenized in 5 ml  of NaCl 0.9% containing Triton X 100 0.5%, fol-
lowed by sonication for 30 s. After a 10-fold dilution, one sample was transferred to
Neubauer chambers (4 ﬁelds per animal), and mature spermatids were counted. To
calculate the daily sperm production (DSP), the number of spermatids at stage 19
was  divided by 6.1, which is the number of days, of the seminiferous cycle during
which these spermatids are present in the seminiferous epithelium. In the same
manner, caput/corpus and cauda epididymidis portions were cut into small frag-
ments with scissors and homogenized, and sperm counted as described for the
testis. The sperm transit time through the epididymis was determined by dividing
the  number of sperm in each portion by DSP.
2.5. Statistical analysis
For comparison of results between the experimental groups, parametric Stu-
dent’s t test or nonparametric Mann–Whitney test was performed, according to
the  characteristics of each variable. Differences were considered signiﬁcant when
p  < 0.05. The statistical analyses were performed by GraphPad InStat (version 3.02).
3. Results
3.1. Experiment 1
Body weight gain was  similar between experimental groups
during the treatment as well as after this period (data not shown).
There was  a signiﬁcant delay in the age of preputial separation in
the ﬂutamide group (Table 1), with treated males presenting with
a 1 day delay in separation. At adulthood (PND 70), sexual behav-
ior parameters were similar between the experimental groups
(Table 1). Similarly, there were no differences between control and
ﬂutamide treated males with respect to fertility following natural
Table 2
Fertility and reproductive performance of male rats after natural mating and artiﬁcial insemination.
Natural Mating Artiﬁcial Insemination
Control (n = 10) Flutamide (n = 10) Control (n = 10) Flutamide (n = 9)
aBody weight of dams (g) 336.91 ± 6.01 329.26 ± 8.88 336.18 ± 7.35 328.92 ± 5.80
aUterus weight with fetuses (g) 58.67 ± 2.35 60.34 ± 3.40 58.89 ± 3.42 43.79 ± 5.50*
aNumber of corpora lutea 12.58 ± 0.42 12.91 ± 0.53 12.80 ± 0.59 12.22 ± 0.52
aImplant number 12.08 ± 0.54 12.45 ± 0.49 12.10 ± 0.62 9.56 ± 0.80*
aReapsortions number 0.92 ± 0.40 1.09 ± 0.55 0.30 ± 0.15 0.33 ± 0.24
aNumber of fetuses 11.17 ± 0.56 11.36 ± 0.65 11.80 ± 0.63 8.89 ± 0.99*
aFetus weight (g) 3.45 ± 0.07 3.50 ± 0.10 3.04 ± 0.05 3.13 ± 0.06
bFertility potential (%) 100.00 (92.15–100.00) 100.00 (96.67–100.00) 100.00 (92.45–100.00) 84.62 (61.54–91.67)*
bPre-implantation loss (%) 0.00 (0.00–7.85) 0.00 (0.00–3.33) 0.00 (0.00–7.56) 15.39 (8.33–38.46)*
bPost-implantation loss (%) 7.69 (0.00–8.52) 0.00 (0.00–12.14) 0.00 (0.00–5.00) 0.00 (0.00–0.00)
a Values expressed as mean ± SEM. Student’s t test.
b Values expressed as median and interquartile intervals. Mann–Whitney test.
* p < 0.05.
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Fig. 1. Serum hormone levels (ng/ml) in rats from control and ﬂutamide groups at
50 and 80 days of age. Values expressed as mean ± SEM. Mann–Whitney test.
mating. There was also no differences in other fertility indices
(Table 2).
Final body weight was similar between control and ﬂutatmide
treated males at both PND 50 and PND 80 (Table 3). On PND 50, the
absolute and relative weights of reproductive organs (epididymis,
prostate, full and empty seminal vesicle and vas deferens) were
signiﬁcantly decreased in the ﬂutamide treated males compared to
controls; testis weight was similar between the groups (Table 3). On
PND 80 reproductive organ weights had recovered with the excep-
tion of the seminal vesicles; full seminal vesicle weight was  still
reduced in ﬂutamide treated males (Table 3).
On PND 50 there was a 41.38% reduction in serum testosterone
levels in ﬂutamide-treated males (p = 0.059) compared to controls.
Serum LH and FSH levels were unaffected by ﬂutamide treatment
in these same animals (Fig. 1). On PND 80 there were no differences
in serum hormone levels between the two groups (Fig. 1).
Qualitative evaluations of sperm showed a statistically signiﬁ-
cant reduction in type A sperm (motile, with progressive trajectory)
in adult rats exposed to ﬂutamide compared to the control group.
Consequently, the percentage of type B sperm (without progressive
motility) was signiﬁcantly increased in the ﬂutamide group (Fig. 2).
Sperm morphology assessments revealed that the percentages of
both abnormal and normal sperm were similar between exper-
imental groups (Table 4). In both control and ﬂutamide treated
males the cytoplasmic droplet was present in the majority of sper-
matozoa (Table 4).
A quantitative evaluation of the two-dimensional proﬁle of pro-
teins extracted from the plasma membrane of proximal cauda
epididymal sperm indicated that 3 proteins changed signiﬁcantly
in the ﬂutamide treated males compared to control males, i.e. spots
30, 54, 112 (Fig. 3). The identiﬁcation of these proteins by MALDI
Fig. 2. Sperm motility of rats from control (n = 10) and ﬂutamide (n = 10) groups.
Values expressed as median. Mann–Whitney test. *p < 0.05.
MSMS  revealed that S112, which was down-regulated by ﬂu-
tamide treatment, is RB11A, while S30 and S54, both up-regulated
by ﬂutamide treatment, are cytochrome b5 type B (CYB5B) and
calmodulin OS (CALM) respectively (Fig. 3).
3.2. Experiment 2
The fertility of proximal cauda epididymal sperm of adult
males, assessed following in utero insemination, was signiﬁcantly
altered by prepubertal ﬂutamide treatment. In addition, there was
a decrease in the number of fetuses (Table 2). The number of
mature testicular spermatids and the DSP were similar for con-
trol and ﬂutamide treated males. However, the number of sperm in
both the proximal (caput/corpus) and distal (cauda) regions of the
epididymis were signiﬁcantly reduced in ﬂutamide treated males
(Table 4). Thus, there was a signiﬁcant reduction in the sperm
transit time through these regions, i.e. sperm transit was accel-
erated throughout the epididymis following ﬂutamide treatment
(Table 4).
4. Discussion
The ﬁnal stages of sperm differentiation occur outside the gonad,
in the epididymal duct [32]. The functions of the epididymis are to
facilitate a transition of testicular spermatozoa to functional matu-
rity, and store mature sperm until they are ejaculated or voided
in the urine [33]. Since sperm released from the seminiferous
epithelium are transcriptionally inactive, the facets of maturation
within the epididymis depend on protein and lipid alterations in the
sperm that are a function of the luminal microenvironment of the
epididymis [32,33].  The intraluminal microenvironment within a
given region of the epididymis reﬂects the secretory and absorptive
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Table 3
Final body weight and absolute and relative reproductive organ weights of male rats from control group and futamide group at 50 and 80 days old.
Experimental Groups
50 days old 80 days old
Control (n = 10) Flutamide (n = 10) Control (n = 10) Flutamide (n = 10)
Final body weight (g) 219.52 ± 7.82 234.89 ± 7.77 356.03 ± 8.04 363.54 ± 9.68
Testes  (g) 1.08 ± 0.03 1.09 ± 0.05 1.54 ± 0.05 1.62 ± 0.05
Testes  (mg/100 g) 495.09 ± 15.57 465.85 ± 22.62 434.56 ± 16.34 449.33 ± 17.99
Epididymis (mg) 164.23 ± 7.21 101.63 ± 5.35** 486.32 ± 7.91 467.52 ± 11.72
Epididymis (mg/100 g) 74.95 ± 2.65 43.72 ± 2.80** 136.96 ± 2.57 129.12 ± 3.73
Ventral  prostate (mg) 133.54 ± 11.31 78.22 ± 7.59* 311.94 ± 15.18 310.11 ± 28.94
Ventral  prostate (mg/100 g) 60.93 ± 4.51 33.78 ± 3.68* 87.79 ± 4.37 84.93 ± 7.64
Vas  deferens (mg) 50.35 ± 2.18 37.58 ± 1.88* 96.82 ± 1.90 89.70 ± 2.41
Vas  deferens (mg/100 g) 23.05 ± 1.03 16.11 ± 0.89** 27.25 ± 0.55 24.75 ± 1.15
Seminal  Vesicle full (mg) 241.27 ± 27.12 83.99 ± 8.76* 946.85 ± 24.68 735.84 ± 41.05**
Seminal Vesicle empty (mg) 106.78 ± 8.51 53.07 ± 4.94* 294.23 ± 16.00 259.44 ± 12.28
Values expressed as mean ± SEM. Mann–Whitney test.
* p ≤ 0.001.
** p ≤ 0.0001.
Table 4
Sperm count parameters (75 day-old animals) and sperm morphology (80 day-old animals) of male rats from control and ﬂutamide groups.
Control (n = 9) Flutamide (n = 10)
Spermatid number (×106/testis)a 249.36 ± 6.94 250.91 ± 6.92
Spermatid number (×106/g testis)a 171.29 ± 5.15 172.32 ± 4.85
Daily  sperm production (×106/testis/day)a 40.88 ± 1.14 41.13 ± 1.13
Relative sperm production (×106/g testis/day)a 28.08 ± 0.84 28.25 ± 0.79
Caput/corpus epididymis sperm number (×106/organ)a 113.72 ± 4.57 90.51 ± 6.66*
Caput/corpus epididymis sperm number (×106/g organ)a 625.99 ± 37.86 539.81 ± 44.96
Sperm transit time in the caput/corpus epididymis (days)a 2.80 ± 0.14 2.21 ± 0.17*
Cauda epididymis sperm number (106/organ)a 144.61 ± 10.10 113.74 ± 9.39*
Cauda epididymis sperm number (106/g organ)a 1 360.0 ± 101.37 1 415.3 ± 120.14
Sperm transit time in the cauda epididymis (days)a 3.54 ± 0.22 2.76 ± 0.21*
Normal shaped sperm (%)b 90.25 (85.75–91.50) 92.50 (84.37–95.37)
Sperm with cytoplasmic droplet (%)b 77.00 (65.37–82.87) 72.00 (65.37–81.87)
a Values expressed as mean ± SEM. Mann–Whitney test.
b Values expessed as median and interquartile intervals. Mann–Whitney test.
* p < 0.05.
Fig. 3. Two  dimensional proteome of proximal cauda sperm plasma membrane proteins of control (A) and ﬂutamide group (B). Numbered spots indicate proteins differentially
expressed following ﬂutamide treatment. (C) Graph showing the treatment-related changes in spot area after background correction (IOD or integrated optical density units)
of  CALM, RB11A and CYB5B proteins (n = 7/group).
J.E. Perobelli et al. / Reproductive Toxicology 33 (2012) 308– 315 313
activities of epididymal epithelium in that region [32,34].  Speciﬁc
secretory and absorptive activities are then pivotal to sperm mat-
uration [32,35].
The differentiated functions of speciﬁc epididymal regions are
established during the period of postnatal development of the
organ, from PND 15 to 44 under the inﬂuence of androgen [6].  Given
the current speculation that chemical stressors (e.g. EDCs) are com-
promising male reproductive development it is important to better
characterize the role in which androgen plays during this critical
developmental window.
In the present study, the absence of changes in body weight
during the experimental period, as well as in the ﬁnal body weight,
indicates that the antiandrogen exposure did not induce systemic
toxicity. Thus, body weight gain was not a contributing factor in any
observed reproductive effects of prepubertal antiandrogen expo-
sure.
According to Ashby and Lefevre [36], changes in reproductive
organ weights and the day of preputial separation are the two  main
parameters for detecting antiandrogens in peripubertal male rat
assays. Thus, in the present study, the delay in the day when the pre-
puce ﬁrst separates from the glans penis in the ﬂutamide-treated
animals is indicative of the antiandrogen activity of this chemical
and suggests impaired of reproductive development.
As previously reported in a study assessing prepubertal expo-
sure to the antiandrogen vinclozolin [37], no changes were
observed in testis weight. The decreased weights of the epididymis,
vas deferens, seminal vesicles and prostate in ﬂutamide-treated
rats on PND 50 suggests compromised development of these
androgen-dependent organs due to impaired androgen availabil-
ity and action, as well as by reduced serum testostereone levels.
On PND 80 only the seminal vesicle weights were reduced in the
ﬂutamide-treated males indicating that during the 35-days follow-
ing ﬂutamide treatment (from PND 44 to 80) was sufﬁcient for the
growth recovery of most reproductive organs.
The observed 41.38% reduction in serum testosterone levels
in ﬂutamide-treated males on PND 50 was probably due to a
direct effect of ﬂutamide on Leydig cells in the testis rather than
alteration of the hypotalamic-pituitary-gonadal axis since FSH
and LH levels were unaffected by ﬂutamide treatment. Accord-
ing to Blystone et al. [15], this lack of responsiveness of the
hypothalamus–pituitary axis to lower serum testosterone after
antiandrogenic exposure is not attributable to the immaturity of
the axis, since pubertal exposure to other AR antagonists such as
vinclozolin produces dramatic increases in serum LH [37].
Biologically, puberty is deﬁned as that time when spermatogen-
esis ﬁrst completes its entire cycle and sperm enter the epididymis,
which occurs around PND 50 in Wistar rats [30]. In the rat, within a
week after these sperm enter the epididymis, fertile sperm can be
recovered from the proximal cauda epididymis. The sperm produc-
tion/g of testis increases until PND 75, and the sperm reserves in
the epididymal cauda are maximal around 100 days of age [30]. In
the present study was used male rats at 75 days old and, although
their sperm reserves are not maximal, the sperm that are present
are fertile and, therefore, it was possible evaluate sperm quality
parameters and fertility after artiﬁcial insemination
Sexual behavior and performance are regulated by com-
plex mechanisms that involve physiological, neurological, neu-
roanatomical and endocrinological aspects [38]. The sexual
behavior of male rats is characterized by a series of mounts, with or
without vaginal intromission, that eventually lead to an ejaculation
[39]. That sexual behavior was unaltered in adults after prepubertal
antiandrogen exposure is consistent with the normal serum levels
of testosterone in these animals.
Evaluation of reproductive parameters after natural mating did
not reveal any impairment in the fertility capacity of adult males
exposed to ﬂutamide prior to puberty. However, this is most likely
attributed to the lack of sensitivity afforded by natural mating ani-
mals with inherently robust sperm production and sperm quality
[20,40]. For example, male rats and rabbits fertilize successfully
even when 90% of their sperm reserves are depleted [41]. Artiﬁcial
insemination has been used successfully as a strategy to evaluate
sperm quality following toxicant exposure [20,42]. In this tech-
nique only a ﬁxed, limiting number of sperm is inseminated to
achieve 80% control fertility; sperm are not inseminated in excess
and the sperm reserves in the epididymal cauda is not a interfering
factor. This increases the likelihood of detecting a toxicant-induced
change. Indeed, the fertility potential, the endpoint which quan-
tiﬁes male fertile capacity, was decreased in the ﬂutamide group
after in utero insemination. In this study, although sperm were not
inseminated in excess, the fertility of control males was essentially
100%. The observed fertilization rate for ﬂutamide-treated males
was  85%. We  speculate that if control fertility had been around the
target, i.e. 75–80%, the resultant fertility in the treated group (i.e.
60–65%) would likely have biological signiﬁcance. As it stands, it
is questionable if sperm with 85% fertilizing potential are indeed
compromised. Another important point to consider is the sample
size used for fertility assessment (n = 10). The use of a larger number
of experimental animals could improve the statistical power.
Sperm motility is an important parameter to evaluate sperm
quality and fertilizing potential [41]. The present study showed
a decrease in the motility of sperm from adult males follow-
ing ﬂutamide-treatment. The observed decrease in sperm motility
may  be related to the fact that sperm transit through the epi-
didymis was  accelerated in these rats. It has been known for
some time that castration with or without androgen replace-
ment accelerates sperm transit through the epididymis [43]. More
recent work using an adult castrate testosterone-implanted animal
model demonstrated that exposure to a chemical that decreases
serum testosterone such as chloroethylmethanesulphonate, or
exposure to the metabolite of ﬂutamide, hydroxyﬂutamide, accel-
erates sperm transit through the epididymis [44]. Thus, reduced
levels of androgen in the epididymis, as well as inhibited action of
androgen in the epididymis, leads to accelerated sperm transit. It is
reasonable to conclude that acceleration of sperm through the epi-
didymis compromises sperm maturation, i.e. sperm motility and
fertilizing potential. Indeed, both chloroethylmethanesulphonate
and hydroxyﬂutamide exposures were shown to result in signif-
icantly reduced fertility following in utero insemination [44,45].
It is therefore, reasonable to assume that the decrease in fertility
observed in the present study is at least in part due to maturational
compromise caused by accelerated sperm transit. That accelerated
transit was  observed on PND 75 when organ weights and hormone
levels were restored suggests that the prepubertal exposure caused
persistent alterations in the development of the epididymis. It will
be important to characterize the proteome of the epididymis to
determine which androgen-dependent proteins failed to become
expressed, and/or persist during development.
The observed proteomic alterations in the cauda epididymal
sperm plasma membrane following ﬂutamide treatment may be
related to the lower sperm quality observed in ﬂutamide group.
Unfortunately, there are currently no data in the literature relating
these proteins to fertility. Calmodulin (CALM) expression, which
was  upregulated by the antiandrogen exposure, is a protein affected
by androgens in rat prostate cells [46]. It has been suggested that
androgen receptors may  play a role in CALM action, which has an
important association with the proliferation and differentiation of
a variety of cells [47]. RB11A, which was  down-regulated by fol-
lowing ﬂutamide treatment is a member of GTP-binding proteins
of the Rab family. These have been implicated as key regulators of
membrane and protein trafﬁcking in mammalian cells [48]. Sheach
et al. [49] suggested that G-proteins are upregulated in response to
androgen stimulation in ovarian cancer samples. This is therefore
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consistent with the observed downregulation of RB11A protein in
ﬂutamide-exposed animals at adulthood. Again, such changes in
the sperm membrane proteome represent persistent alterations
resulting from ﬂutamide exposure during the prepubertal period
of development and may  reﬂect alterations induced in the testis as
well as the epididymis. Previous studies using intact and castrated
T-implanted adult animals exposed to hydroxyﬂutamide during 5
days have demonstrated direct effects of the toxicant on the epi-
didymis [26,44]. In the present study, while testicular effects cannot
be completely excluded, although we did not ﬁnd alterations in DSP,
sperm morphology, and testis histopatology, we  can suggest that
the observed effects appear to be related to the altered develop-
ment of the epididymis. More studies are necessary to characterize
the molecular changes which persist in both the epididiymis and
epididymal sperm subsequent to impaired androgen stimulation
during the prepubertal period of reproductive development.
5. Conclusion
We can conclude that, interfering with androgen action during
the prepubertal period compromises reproductive competence at
adulthood. Signiﬁcant alterations in both the quantity and qual-
ity of sperm in the epididymis are observed at adulthood. These
alterations are independent of hormone status and organ weight at
adulthood indicating that speciﬁc molecular events pivotal to nor-
mal  differentiation of the epididymis either fail to occur or fail to
persist into adulthood.
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